Abstract:
Continuous format high throughput screening (CF-HTS) using at least one porous matrix allows the pharmaceutical industry to simultaneously screen large numbers of chemical entities for a wide range of biological or biochemical activity. In addition, CF-HTS is useful to perform multi-step assays.
Abstract:
A method for testing a multiplicity of chemical entities for the ability of these chemical entities to enhance or inhibit abiological process. In one embodiment, the method comprises the steps of: (a) providing a blank matrix having at least two major surfaces, the at least two major surfaces capable of receiving assay components and chemical entities; (b) applying at least one chemical entity to at least one of the at least two major surfaces of the blank matrix, whereby an impregnated matrix is formed; (c) applying to at least one of the at least two major surfaces ofthe impregnated matrix at least one assay component required for a biological process; and (d) evaluating the ability of the at least one chemical entity to enhance or inhibit the biological process involving the at least one assaycomponent. In the preferred embodiments, a response indicative of an enhancement or an inhibition of the aforementioned biological process can be detected by a tracer, which can be introduced to the impregnated matrix as an assay component. The response so detected can be preserved in the form of an image of the at least one of the two major surfaces of the impregnated matrix.
Abstract:
Zpusob soucasného testování množství vzorku ruzných látek na jejich zpusobilost zesilovat nebo inhibovat biologický proces, zahrnuje (g) uložení malého objemu každého z více než 96 vzorku rozdílnýchlátek v usporádání na matrici tak, že každá jednotlivá látka je soustredena na své vlastní odlišenémísto a identita každé látky muže být urcena z jejího místa uložení, (h) uvedení této matrice do styku s první porézní matricí obsahující nebo nesoucí rovnomerne rozptýlené zkušební cinidlo a umožnení, aby cást z každé látky difundovala do uvedené porézní matrice takovým zpusobem, že prostorové umístení každé difundované látky muže být korelováno s místem na uvedené matrici, na kterém byla uvedená látka puvodne uložena, a (i) provedení testu prostanovení zpusobilosti každé difundované látky zesilovat nebo inhibovat uvedený biologický proces pozorováním interakce každé látky s uvedeným zkušebním cinidlem, kde uvedenou matricí je planární matrice.
Abstract:
Un procedimiento para ensayar simultáneamente una multitud de muestras de diferentes sustancias, por su capacidad para intensificar o inhibir un proceso biológico, comprendiendo: a) depositar en un array un pequeño volumen de cada una de más de 96 muestras de sustancias diferentes sobre una matriz, de manera que cada sustancia diferente esté centrada en su propio sitio diferente, y se pueda determinar la identidad de cada sustancia a partir de su sitio de deposición, b) poner en contacto dicha matriz con una primera matriz porosa conteniendo, o llevando, un primer reactivo de ensayo uniformemente dispersado, y dejar que algo de cada sustancia se difunda dentro de dicha matriz porosa de manera que la ubicación espacial de cada sustancia difundida pueda ser correlacionada con el sitio en dicha matriz en el que dicha sustancia fue originalmente depositada, y c) conducir un ensayo para determinar la capacidad de cada sustancia difundida para intensificar o inhibir dicho proceso biológico, observando la interacción de cada sustancia con dicho reactivo de ensayo, caracterizado por que dicha matriz es una matriz planar.
Abstract:
Continuous format high throughput screening (CF-HTS) using at least one porous matrix allows the pharmaceutical industry to simultaneously screen large numbers of chemical entities for a wide range of biological or biochemical activity. In addition, CF-HTS is useful to perform multi-step assays.
Abstract:
A method for testing a multiplicity of chemical entities for the ability of these chemical entities to enhance or inhibit abiological process. In one embodiment, the method comprises the steps of: (a) providing a blank matrix having at least two major surfaces, the at least two major surfaces capable of receiving assay components and chemical entities; (b) applying at least one chemical entity to at least one of the at least two major surfaces of the blank matrix, whereby an impregnated matrix is formed; (c) applying to at least one of the at least two major surfaces ofthe impregnated matrix at lea st one assay component required for a biological process; and (d) evaluating th e ability of the at least one chemical entity to enhance or inhibit the biological process involving the at least one assaycomponent. In the preferr ed embodiments, a response indicative of an enhancement or an inhibition of the aforementioned biological process can be detected by a tracer, which can be introduced to the impregnated matrix as an assay component. The response so detected can be preserved in the form of an image of the at least one of the two major surfaces of the impregnated matrix.
Abstract:
Continuous format high throughput screening (CF-HTS) using at least one porous matrix allows the pharmaceutical industry to simultaneously screen large numbers of chemical entities for a wide range of biological or biochemical activity. In addition, CF-HTS is useful to perform multi-step assays.
Abstract:
Continuous format high throughput screening (CF-HTS) using at least one porous matrix allows the pharmaceutical industry to simultaneously screen large numbers of chemical entities for a wide range of biological or biochemical activity. In addition, CF-HTS is useful to perform multi-step assays.
Abstract:
A process to simultaneously test a multitude of samples of different substances for their ability to enhance or inhibit a biological process comprising, a) depositing in an array a small volume of each of more than 96 samples of distinct substances onto a planar porous matrix containing or carrying a uniformly dispersed assay reagent such that each distinct substance is centered at its own distinct site and the identity of each substance can be determined from its deposition site, and b) observing the interaction of each substance with said assay reagent and correlating it to said substance's ability to enhance or inhibit said biological process. Continuous format high throughput screening (CF-HTS) using at least one porous matrix allows simultaneous screening of large numbers of chemical entities for a wide range of biological or biochemical activity, and CF-HTS is also useful to perform multi-step assays.